Arabic Arabic English English French French German German
dark

Ziopharm Eliminates 60 Positions in Strategic Workforce Reduction

Less than a month after appointing a new chief executive officer, Ziopharm Oncology announced a restructure that has resulted in over 50% of its workforce being axed. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Which programs are thriving for a five-star performer?

Next Post

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan

Related Posts
Total
0
Share